title: In vivo antitumor activity by 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone in a solid human carcinoma xenograft model.
abstract: Previously, we showed that 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone (DMC), isolated from the buds of Cleistocalyx operculatus, significantly inhibited the growth of human liver cancer SMMC-7721 cells and could induce SMMC-7721 cells apoptosis in vitro. Here, we report the antitumor effects of DMC in vivo, using a solid human tumor xenograft model with a human liver cancer SMMC-7721 cell line. Our results revealed that the average tumor weight in a control group and a 150-mg/kg DMC injection group was 1.42+/-0.11 g and 0.59+/-0.12 g, respectively. Flow cytometric analysis of the tumor cell population demonstrated the existence of an aneuploid peak (representing 33.60+/-0.80% of the total in the 150-mg/kg DMC injection group). To our knowledge, this is the first time that chalcone compounds were applied to a human tumor xenograft model.
authors.affiliation: State Key Laboratory of Bioreactor Engineering, Institute of Biochemistry, East China University of Science and Technology, Shanghai, 200237, China.
authors.forename: Chun-Lin
authors.initials: CL
authors.lastname: Ye
authors.forename: Jian-Wen
authors.initials: JW
authors.lastname: Liu
authors.forename: Dong-Zhi
authors.initials: DZ
authors.lastname: Wei
authors.forename: Yan-Hua
authors.initials: YH
authors.lastname: Lu
authors.forename: Feng
authors.initials: F
authors.lastname: Qian
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor / Q000187:drug effects; D002599:Chalcone / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity*; D047188:Chalcones; D005434:Flow Cytometry; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008813:Mice, Inbred ICR; D023041:Xenograft Model Antitumor Assays / Q000379:methods*
chemical_list: D047188:Chalcones; D002599:Chalcone; C105002:angoletin